I think you can stop wondering if production capacity has been kept quiet. When TDA moves shifts away from wondering openly about the prospects of Praluent/Alirocumab then I suspect that says a lot. Indi and TDA were the biggest proponents of that theory. Sadly most every OPTIMISTIC assumption we've had for UNS has never materalized. Fortunately, we don't need the high-end expectations to make good money. What bumms be out from time to time is that even my cautious expecctations are not being met of late. Again, not saying UNS isn't executing and that things are not progressing. They just are not moving as quickly as stick-in-the-mud Karl would have thought. ugh! Had I had expected as much as some around here, I'd be eating prozac like candy. lol
UNS Price at posting:
85.0¢ Sentiment: Hold Disclosure: Held